Celldex Therapeutics Inc. (CLDX)
NASDAQ: CLDX
· Real-Time Price · USD
25.48
0.54 (2.17%)
At close: Aug 15, 2025, 3:59 PM
25.50
0.08%
After-hours: Aug 15, 2025, 04:54 PM EDT
Celldex Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -56.6M | -53.8M | -47.09M | -42.12M | -35.84M | -32.81M | -43.31M | -38.26M | -30.5M | -29.36M | -26.49M | -26.78M | -36M | -23.05M | -20.15M | -20.45M | -13.37M | -16.54M |
Depreciation & Amortization | 873K | 867K | 819K | -11.6M | 797K | 775K | 759K | 767K | 756K | 726K | 673K | 671K | 741K | 811K | 777K | 752K | 764K | 775K |
Stock-Based Compensation | 9.19M | 9.32M | 9.78M | 9.62M | 7.64M | 7.2M | 7.21M | 7.12M | 5.22M | 4.34M | 4.51M | 4.5M | 3.45M | 3.15M | 3.14M | 3.03M | 1.51M | 1.27M |
Other Working Capital | 1.16M | 586K | -770K | -26.68M | -33K | -7.68M | 3.48M | 4.66M | -3.18M | 4.42M | -2.18M | -15.07M | 13.28M | -2.88M | -165K | -590K | -2.81M | -2.71M |
Other Non-Cash Items | -1.69M | -2.26M | -3.36M | 8.06M | -4.74M | -3.31M | -42.07M | 38.26M | -1.16M | -1.26M | -521K | 1.58M | -5.73M | 236K | -275K | -1.63M | 258K | 483K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 39.89M | -39.89M | n/a | n/a | n/a | n/a | n/a | n/a | 227K | -227K | -125K | -72K |
Change in Working Capital | 4.22M | -8.5M | 7.38M | -19.29M | 2.82M | -12.5M | 4.98M | 13.01M | -1.51M | -3.02M | 65K | -13.58M | 15.3M | -5.68M | 1.76M | 2.16M | -963K | -4.01M |
Operating Cash Flow | -44.01M | -54.37M | -32.48M | -55.34M | -29.33M | -40.64M | -32.53M | -18.99M | -27.2M | -28.57M | -21.76M | -35.19M | -22.24M | -24.53M | -14.52M | -16.37M | -11.93M | -18.08M |
Capital Expenditures | -728K | -265K | -756K | 618K | -274K | -344K | -666K | -157K | -410K | -585K | -235K | -345K | -673K | -575K | -354K | -185K | -143K | -567K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -585K | -11.8M | -1.57M | 585K | 69K | n/a | -25.95M | 575K | 2K | 1K | n/a | 24K |
Purchase of Investments | -122.26M | -151.82M | -129.18M | -100.06M | -168.51M | -392.18M | -241.39M | -27.75M | -81.58M | -73.85M | -56.35M | -62.77M | -52.96M | -16.89M | -64.54M | -239.6M | -51.77M | -33.97M |
Sales Maturities Of Investments | 172.84M | 195.04M | 153.98M | 148.36M | 122.06M | 77.31M | 70.89M | 39.55M | 83.15M | 127M | 87.8M | 86.11M | 78.91M | 27.84M | 45.95M | 13M | 38M | 78M |
Other Investing Acitivies | n/a | n/a | n/a | -1.16M | n/a | n/a | 585K | 11.8M | 1.57M | -585K | -69K | 23.41M | 25.95M | -575K | 2K | 1K | -13.77M | 24K |
Investing Cash Flow | 49.85M | 42.95M | 24.05M | 47.76M | -46.72M | -315.21M | -171.16M | 11.65M | 1.16M | 52.57M | 31.21M | 23.07M | 25.28M | 10.38M | -18.94M | -226.79M | -13.91M | 43.49M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 432.68M | n/a | n/a | 3.81M | n/a | n/a | 133K | 694K | 1.4M | 2.31M | 71K | 304K | 426K | 2M | -25K | 74K |
Financial Cash Flow | 63K | 202K | 386K | 1.24M | 3.71M | 436.11M | 217.37M | 257K | 133K | 694K | 1.4M | 2.31M | 71K | 304K | 426K | 271.9M | -25K | 74K |
Net Cash Flow | 5.91M | -11.22M | -8.04M | -6.34M | -72.34M | 80.26M | 13.68M | -7.09M | -25.9M | 24.69M | 10.85M | -9.82M | 3.11M | -13.85M | -33.04M | 28.74M | -25.87M | 25.48M |
Free Cash Flow | -44.73M | -54.37M | -33.23M | -54.72M | -29.6M | -40.98M | -33.2M | -19.15M | -27.61M | -29.15M | -22M | -35.54M | -22.92M | -25.11M | -14.88M | -16.56M | -12.07M | -18.65M |